scholarly article | Q13442814 |
P50 | author | Ralph Steinman | Q105494 |
P2093 | author name string | I Mellman | |
S Turley | |||
K Inaba | |||
C Reis e Sousa | |||
R N Germain | |||
F Yamaide | |||
S Shimoyama | |||
T Iyoda | |||
P2860 | cites work | Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading | Q24328923 |
Activation of human dendritic cells through CD40 cross-linking. | Q41440958 | ||
Capture and processing of exogenous antigens for presentation on MHC molecules. | Q41464375 | ||
Dendritic cells: unique leukocyte populations which control the primary immune response | Q41621775 | ||
Chemokine Up-regulation and activated T cell attraction by maturing dendritic cells | Q41648813 | ||
Dendritic cells as adjuvants for immune-mediated resistance to tumors | Q41649620 | ||
Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding | Q41731115 | ||
Antigen capture and major histocompatibility class II compartments of freshly isolated and cultured human blood dendritic cells | Q41946843 | ||
Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization | Q42064511 | ||
Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells | Q42259452 | ||
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites | Q42971765 | ||
Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. | Q47872621 | ||
The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. | Q47915773 | ||
The duration of antigenic stimulation determines the fate of naive and effector T cells. | Q51099389 | ||
Analysis of adjuvant function by direct visualization of antigen presentation in vivo: endotoxin promotes accumulation of antigen-bearing dendritic cells in the T cell areas of lymphoid tissue | Q56880741 | ||
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells | Q57275942 | ||
Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes | Q59098594 | ||
A cell culture model for T lymphocyte clonal anergy | Q67299314 | ||
Tachyplesins isolated from hemocytes of Southeast Asian horseshoe crabs (Carcinoscorpius rotundicauda and Tachypleus gigas): identification of a new tachyplesin, tachyplesin III, and a processing intermediate of its precursor | Q68585489 | ||
An improved isolation method for murine migratory cutaneous dendritic cells | Q71217258 | ||
Both dendritic cells and memory T lymphocytes emigrate from organ cultures of human skin and form distinctive dendritic-T-cell conjugates | Q72353140 | ||
Transport of peptide-MHC class II complexes in developing dendritic cells | Q73698434 | ||
Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells | Q74310288 | ||
Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells | Q74440382 | ||
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation | Q77353738 | ||
Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells | Q24653129 | ||
Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation | Q24677534 | ||
Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products | Q24678867 | ||
Dendritic cells and the control of immunity | Q27860918 | ||
EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation | Q28282903 | ||
The invariant chain is required for intracellular transport and function of major histocompatibility complex class II molecules | Q28585584 | ||
MHC class II-associated invariant chain contains a sorting signal for endosomal compartments | Q28612553 | ||
Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor | Q29619247 | ||
Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application | Q33536357 | ||
Production, specificity, and functionality of monoclonal antibodies to specific peptide-major histocompatibility complex class II complexes formed by processing of exogenous protein | Q33731623 | ||
Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. | Q33855405 | ||
Isolation and characterization of the intracellular MHC class II compartment. | Q34340778 | ||
Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain | Q36353782 | ||
Migration and maturation of Langerhans cells in skin transplants and explants | Q36353813 | ||
Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells | Q36356239 | ||
Phagocytosis of antigens by Langerhans cells in vitro | Q36362124 | ||
Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo | Q36362128 | ||
B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance | Q36362561 | ||
Resting and anergic B cells are defective in CD28-dependent costimulation of naive CD4+ T cells. | Q36363106 | ||
The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy | Q36363714 | ||
The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro | Q36363984 | ||
B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells | Q36364036 | ||
High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. | Q36367475 | ||
Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma | Q36375683 | ||
Related leucine-based cytoplasmic targeting signals in invariant chain and major histocompatibility complex class II molecules control endocytic presentation of distinct determinants in a single protein | Q36376527 | ||
Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures | Q36376739 | ||
High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes | Q36380488 | ||
Antigen-unspecific B cells and lymphoid dendritic cells both show extensive surface expression of processed antigen-major histocompatibility complex class II complexes after soluble protein exposure in vivo or in vitro. | Q36380500 | ||
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells | Q36401207 | ||
Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment | Q38138330 | ||
Origin, maturation and antigen presenting function of dendritic cells. | Q40906220 | ||
How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway | Q41020969 | ||
Developmental regulation of MHC class II transport in mouse dendritic cells. | Q41093187 | ||
HLA-DM is localized to conventional and unconventional MHC class II-containing endocytic compartments. | Q41224482 | ||
Accumulation of HLA-DM, a regulator of antigen presentation, in MHC class II compartments | Q41412265 | ||
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
inflammation | Q101991 | ||
P304 | page(s) | 927-936 | |
P577 | publication date | 2000-03-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli | |
P478 | volume | 191 |
Q37409898 | A West Nile virus NS4B-P38G mutant strain induces adaptive immunity via TLR7-MyD88-dependent and independent signaling pathways |
Q34492984 | A closer look at proteolysis and MHC-class-II-restricted antigen presentation. |
Q44791801 | A cytosolic pathway for MHC class II-restricted antigen processing that is proteasome and TAP dependent |
Q49597523 | A major isoform of the E3 ubiquitin ligase March-I in antigen presenting cells has regulatory sequences within its gene |
Q59487689 | A study of dendritic cell and MHC class II expression in dogs with immunomodulatory-responsive lymphocytic-plasmacytic pododermatitis |
Q36399030 | Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis |
Q36371349 | Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein |
Q35087645 | Alternatives to immunosuppressive drugs in human islet transplantation |
Q40375320 | An appreciation of Ralph Marvin Steinman (1943–2011). |
Q36368582 | Anti-interleukin 10 receptor monoclonal antibody is an adjuvant for T helper cell type 1 responses to soluble antigen only in the presence of lipopolysaccharide |
Q26768528 | Antibody Targeting of "Steady-State" Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells |
Q38874605 | Antigen Processing and Presentation Mechanisms in Myeloid Cells |
Q34129315 | Antigen processing in the endocytic compartment |
Q40011864 | Appropriate timing of CD40 ligation for RNA-Pulsed DCs to induce antitumor immunity |
Q38063965 | Assessment of immunotoxicity using precision-cut tissue slices. |
Q51981447 | Assessment of myosin II, Va, VI and VIIa loss of function on endocytosis and endocytic vesicle motility in bone marrow-derived dendritic cells. |
Q36618394 | Autoimmunity versus tolerance: can dying cells tip the balance? |
Q36221894 | Autonomous phagosomal degradation and antigen presentation in dendritic cells |
Q33897693 | Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance |
Q24537365 | Biogenesis of Leishmania major-harboring vacuoles in murine dendritic cells |
Q43805226 | Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation |
Q44622580 | Carbon monoxide decreases endosome-lysosome fusion and inhibits soluble antigen presentation by dendritic cells to T cells. |
Q41758639 | Carbon monoxide down-modulates Toll-like receptor 4/MD2 expression on innate immune cells and reduces endotoxic shock susceptibility. |
Q36266181 | Cdc42-dependent actin dynamics controls maturation and secretory activity of dendritic cells |
Q33902421 | Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8alpha+ dendritic cells |
Q52330706 | Chlamydia and Lipids Engage a Common Signaling Pathway That Promotes Atherogenesis. |
Q78476270 | Co-stimulatory and adhesion molecules of dendritic cells in rheumatoid arthritis |
Q38981348 | Combination of In Silico Methods in the Search for Potential CD4(+) and CD8(+) T Cell Epitopes in the Proteome of Leishmania braziliensis. |
Q36371928 | Complex carbohydrates are not removed during processing of glycoproteins by dendritic cells: processing of tumor antigen MUC1 glycopeptides for presentation to major histocompatibility complex class II-restricted T cells |
Q36371218 | Constitutive presentation of a natural tissue autoantigen exclusively by dendritic cells in the draining lymph node |
Q36266484 | Control of MHC class II antigen presentation in dendritic cells: a balance between creative and destructive forces. |
Q41897237 | Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells |
Q33627385 | DC subset-specific induction of T cell responses upon antigen uptake via Fcγ receptors in vivo. |
Q39193752 | Dendritic Cell KLF2 Expression Regulates T Cell Activation and Proatherogenic Immune Responses |
Q48738306 | Dendritic cell adhesion to cerebral endothelium: role of endothelial cell adhesion molecules and their ligands |
Q34038736 | Dendritic cell based tumor vaccines |
Q41915734 | Dendritic cell maturation enhances CD8+ T-cell responses to exogenous antigen via a proteasome-independent mechanism of major histocompatibility complex class I loading |
Q50335826 | Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. |
Q34023428 | Dendritic cell regulation of TH1-TH2 development |
Q36717351 | Dendritic cell vaccine strategies for renal cell carcinoma |
Q21284774 | Dendritic cell-based approaches for therapeutic immune regulation in solid-organ transplantation |
Q38281782 | Dendritic cell-based vaccine research against cancer. |
Q28480976 | Dendritic cell-mediated vaccination relies on interleukin-4 receptor signaling to avoid tissue damage after Leishmania major infection of BALB/c mice |
Q37746786 | Dendritic cells and macrophages are productively infected by poliovirus |
Q34046816 | Dendritic cells and prospects for transplantation tolerance |
Q36475977 | Dendritic cells in a mature age. |
Q34241103 | Dendritic cells in transplantation--friend or foe? |
Q30080006 | Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo |
Q33963180 | Dendritic cells inhibit the progression of Listeria monocytogenes intracellular infection by retaining bacteria in major histocompatibility complex class II-rich phagosomes and by limiting cytosolic growth |
Q29617085 | Dendritic cells: specialized and regulated antigen processing machines |
Q36986703 | Dendritic cells: understanding immunogenicity |
Q37125939 | Determination of T-cell fate by dendritic cells |
Q50119612 | Developmental control of endocytosis in dendritic cells by Cdc42. |
Q32067271 | Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome |
Q37225614 | Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. |
Q37112621 | Disruption of multivesicular body vesicles does not affect major histocompatibility complex (MHC) class II-peptide complex formation and antigen presentation by dendritic cells |
Q73691187 | Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity |
Q48109150 | Distinct features of dendritic cell-based immunotherapy as cancer vaccines |
Q35928330 | Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy. |
Q77969643 | Effect of liposomal antigens on the priming and activation of the immune system by dendritic cells |
Q59599359 | Effect of sialic acid loss on dendritic cell maturation |
Q41101184 | Effects of anti-infection treatment on expressions of HLA-DR and CD86 in dendritic cells in rabbit buccal VX2 squamous cell carcinoma tissue with inflammation |
Q36376611 | Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance |
Q36436748 | Encounter with antigen-specific primed CD4 T cells promotes MHC class II degradation in dendritic cells |
Q34118627 | Endogenous pro- and anti-inflammatory cytokines differentially regulate an in vivo humoral response to Streptococcus pneumoniae. |
Q37498956 | Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction. |
Q35852370 | Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors |
Q38757979 | Escherichia coli Heat-Labile Enterotoxin B Limits T Cells Activation by Promoting Immature Dendritic Cells and Enhancing Regulatory T Cell Function |
Q24800882 | Evaluation of dendritic cells loaded with apoptotic cancer cells or expressing tumour mRNA as potential cancer vaccines against leukemia |
Q36837378 | Evasion of peptide, but not lipid antigen presentation, through pathogen-induced dendritic cell maturation |
Q33951651 | FRET microscopy autologous tumor lysate processing in mature dendritic cell vaccine therapy |
Q50656819 | Fetal Phagocytes Take up Allergens to Initiate T-Helper Cell Type 2 Immunity and Facilitate Allergic Airway Responses. |
Q27644030 | Fluorogenic probes for monitoring peptide binding to class II MHC proteins in living cells |
Q81527664 | Functional dichotomy of plasmacytoid dendritic cells: antigen-specific activation of T cells versus production of type I interferon |
Q35039002 | Gene-modified dendritic cells for immunotherapy against cancer |
Q78492740 | Generation and characterization of ovine dendritic cells derived from peripheral blood monocytes |
Q37601348 | Generation of tolerogenic dendritic cells via the E-cadherin/beta-catenin-signaling pathway |
Q36369790 | Generation of tumor-associated cytotoxic T lymphocytes requires interleukin 4 from CD8(+) T cells |
Q39787210 | HIV gag protein is efficiently cross-presented when targeted with an antibody towards the DEC-205 receptor in Flt3 ligand-mobilized murine DC. |
Q92809875 | Herpes Simplex Virus Type-2 Paralyzes the Function of Monocyte-Derived Dendritic Cells |
Q34913590 | Human cytomegalovirus decreases constitutive transcription of MHC class II genes in mature Langerhans cells by reducing CIITA transcript levels |
Q36354718 | Human dendritic cell subsets for vaccination |
Q39290449 | Human phagosome processing of Mycobacterium tuberculosis antigens is modulated by interferon-γ and interleukin-10. |
Q35024781 | Human plasmacytoid-derived dendritic cells and the induction of T-regulatory cells |
Q35848573 | Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation |
Q36228368 | Immature monocytes acquire antigens from other cells in the bone marrow and present them to T cells after maturing in the periphery |
Q26777195 | Immunity to Pathogens Taught by Specialized Human Dendritic Cell Subsets |
Q89965517 | Immunogenicity of Potential CD4+ and CD8+ T Cell Epitopes Derived From the Proteome of Leishmania braziliensis |
Q33942185 | In vivo maturation and migration of dendritic cells |
Q34005446 | Incorporation of CD40 ligand into SHIV virus-like particles (VLP) enhances SHIV-VLP-induced dendritic cell activation and boosts immune responses against HIV. |
Q40908427 | Indirect Toll-like receptor 5-mediated activation of conventional dendritic cells promotes the mucosal adjuvant activity of flagellin in the respiratory tract |
Q80577057 | Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: role of B7-H3 expression and antigen presentation |
Q40773193 | Induction of specific CD8+ memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope |
Q56880717 | Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function |
Q36399907 | Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells |
Q42131303 | Internalization and presentation of myelin antigens by the brain endothelium guides antigen-specific T cell migration |
Q81232011 | Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells |
Q35951845 | Is targeting Toll-like receptors and their signaling pathway a useful therapeutic approach to modulating cytokine-driven inflammation? |
Q34355697 | Killing of dendritic cells: a life cut short or a purposeful death? |
Q42110748 | LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells. |
Q37948123 | LTβR and CD40: working together in dendritic cells to optimize immune responses. |
Q26858852 | Leishmania spp. Proteome Data Sets: A Comprehensive Resource for Vaccine Development to Target Visceral Leishmaniasis |
Q36217305 | Lysosomal membrane proteomics and biogenesis of lysosomes |
Q58758033 | MHC Class II Expression Is Regulated in Dendritic Cells Independently of Invariant Chain Degradation |
Q44066966 | Macrophage C-type lectin on bone marrow-derived immature dendritic cells is involved in the internalization of glycosylated antigens |
Q36832560 | Major histocompatibility complex (MHC) class II-peptide complexes arrive at the plasma membrane in cholesterol-rich microclusters |
Q39474621 | Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells |
Q61053890 | Maturation of DC is associated with changes in motile characteristics and adherence |
Q36369559 | Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression |
Q34235880 | Mature T cell seeks antigen for meaningful relationship in lymph node |
Q34250645 | Migration of dendritic cells into lymphatics-the Langerhans cell example: routes, regulation, and relevance. |
Q56875680 | Modulation of dendritic cell endocytosis and antigen processing pathways by Escherichia coli heat-labile enterotoxin and mutant derivatives |
Q35205220 | Modulation of dendritic cell immunobiology via inhibition of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase. |
Q33651251 | Monocyte-Derived Dendritic Cells Exhibit Increased Levels of Lysosomal Proteolysis as Compared to Other Human Dendritic Cell Populations |
Q28612010 | Multiple roles of the invariant chain in MHC class II function |
Q34214364 | Multistep autoactivation of asparaginyl endopeptidase in vitro and in vivo |
Q41902497 | Neuropilin-1 expression on regulatory T cells enhances their interactions with dendritic cells during antigen recognition |
Q39451745 | Old and new adjuvants |
Q47924371 | Phenotypic stability of mature dendritic cells tuned by TLR or CD40 to control the efficiency of cytotoxic T cell priming |
Q34167920 | Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection |
Q38353384 | PolyI:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activation |
Q37191389 | Polymeric linear Peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loading |
Q28611993 | Presentation of antigens by MHC class II molecules: getting the most out of them |
Q36376648 | Presentation of exogenous antigens on major histocompatibility complex (MHC) class I and MHC class II molecules is differentially regulated during dendritic cell maturation |
Q36433065 | Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation |
Q39686166 | Processing and degradation of exogenous prion protein by CD11c(+) myeloid dendritic cells in vitro |
Q34351438 | Processing and presentation of antigens by dendritic cells: implications for vaccines |
Q53963043 | Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs. |
Q35035050 | Proteinases and their inhibitors in the immune system |
Q28612038 | Proteolysis and antigen presentation by MHC class II molecules |
Q26864537 | Pulmonary dendritic cell development and antigen acquisition |
Q44886104 | Pulmonary surfactant protein D: a novel link between innate and adaptive immunity |
Q21296852 | RNA vaccines in cancer treatment |
Q37303927 | Regulation of MHC Class II-Peptide Complex Expression by Ubiquitination |
Q36037772 | Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. |
Q36824687 | Regulatory roles for NKT cell ligands in environmentally induced autoimmunity |
Q42132231 | Reorganization of multivesicular bodies regulates MHC class II antigen presentation by dendritic cells |
Q89813083 | Revisiting cellular immune response to oncogenic Marek's disease virus: the rising of avian T-cell immunity |
Q41578289 | Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes |
Q37276193 | Salmonella polarises peptide-MHC-II presentation towards an unconventional Type B CD4+ T-cell response |
Q34522863 | Secretory lysosomes |
Q36311691 | Skin-sensitizing and irritant properties of propylene glycol |
Q35219290 | Some interfaces of dendritic cell biology |
Q36943066 | Stress-induced neurogenic inflammation in murine skin skews dendritic cells towards maturation and migration: key role of intercellular adhesion molecule-1/leukocyte function-associated antigen interactions |
Q94502896 | São Paulo School of Advanced Sciences on Vaccines: an overview |
Q38287969 | Targeting Dendritic Cells as a Good Alternative to Combat Leishmania spp. |
Q35549421 | Targeting dendritic cells for priming cellular immune responses |
Q77383438 | Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy |
Q26784452 | The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease |
Q34129335 | The cell biology of antigen presentation in dendritic cells. |
Q37082455 | The cell biology of cross-presentation and the role of dendritic cell subsets |
Q38869721 | The comings and goings of MHC class I molecules herald a new dawn in cross-presentation. |
Q34129320 | The control and facilitation of MHC class II antigen processing by the BCR. |
Q82305697 | The delivery of an antigen from the endocytic compartment into the cytosol for cross-presentation is restricted to early immature dendritic cells |
Q38365560 | The ins and outs of MHC class II-mediated antigen processing and presentation |
Q36402640 | The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation |
Q34338355 | Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now? |
Q28612003 | Trafficking of MHC class II molecules in the late secretory pathway |
Q35829758 | Translating cell biology in vitro to immunity in vivo. |
Q37744972 | Tsc1 expression by dendritic cells is required to preserve T-cell homeostasis and response |
Q34377531 | Ubiquitination regulates MHC class II-peptide complex retention and degradation in dendritic cells |
Q39390434 | Vaccinia virus A35R inhibits MHC class II antigen presentation |
Q39753158 | Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. |
Q36178572 | Vaccinia virus infection induces dendritic cell maturation but inhibits antigen presentation by MHC class II. |
Q42801094 | Vascular dendritic cells as gatekeepers of lipid accumulation within nascent atherosclerotic plaques |
Q74309792 | [Dendritic cells and the control of the immune response] |
Q40363063 | gammadelta T cells promote the maturation of dendritic cells during West Nile virus infection |
Search more.